JP7385930B2 - サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 - Google Patents

サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 Download PDF

Info

Publication number
JP7385930B2
JP7385930B2 JP2020569792A JP2020569792A JP7385930B2 JP 7385930 B2 JP7385930 B2 JP 7385930B2 JP 2020569792 A JP2020569792 A JP 2020569792A JP 2020569792 A JP2020569792 A JP 2020569792A JP 7385930 B2 JP7385930 B2 JP 7385930B2
Authority
JP
Japan
Prior art keywords
sugarcane
prebiotic
inflammatory bowel
fiber
bacterial strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020569792A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019237152A5 (enExample
JP2021527104A (ja
Inventor
エリ ラジャマラン
エドワーズ ゴードン
ジョン ニール テイラー ケント
アントニー スタンリー ロジャー
サンデッシュ シンデ タンビ
Original Assignee
ユニバーシティ オブ タスマニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018902145A external-priority patent/AU2018902145A0/en
Application filed by ユニバーシティ オブ タスマニア filed Critical ユニバーシティ オブ タスマニア
Publication of JP2021527104A publication Critical patent/JP2021527104A/ja
Publication of JPWO2019237152A5 publication Critical patent/JPWO2019237152A5/ja
Application granted granted Critical
Publication of JP7385930B2 publication Critical patent/JP7385930B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2020569792A 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 Active JP7385930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902145 2018-06-15
AU2018902145A AU2018902145A0 (en) 2018-06-15 Preparation for the Treatment of Inflammatory Bowel Disease using a Whole Plant Fibre Extract from Sugarcane
PCT/AU2019/050604 WO2019237152A1 (en) 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Publications (3)

Publication Number Publication Date
JP2021527104A JP2021527104A (ja) 2021-10-11
JPWO2019237152A5 JPWO2019237152A5 (enExample) 2022-06-10
JP7385930B2 true JP7385930B2 (ja) 2023-11-24

Family

ID=68841796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569792A Active JP7385930B2 (ja) 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤

Country Status (6)

Country Link
US (1) US20210138002A1 (enExample)
EP (1) EP3806879A4 (enExample)
JP (1) JP7385930B2 (enExample)
AU (1) AU2019285375B2 (enExample)
CA (1) CA3103831A1 (enExample)
WO (1) WO2019237152A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024026529A1 (en) * 2022-08-01 2024-02-08 Health Food Symmetry Pty Ltd Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
BE1031643B1 (nl) * 2023-05-26 2025-01-03 Synero Bv Functionele drank alsook werkwijze voor het vervaardigen en stabiliseren hiervan

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013515051A (ja) 2009-12-22 2013-05-02 プロビ アクティエボラーグ 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用
WO2014162303A1 (en) 2013-04-05 2014-10-09 Gratuk Technologies Pty Ltd Use of a dietary fibre supplement in a food formulation
JP2015510754A (ja) 2012-03-05 2015-04-13 グラタク テクノロジーズ ピーティーワイ リミテッド 栄養補助食品
JP2015126727A (ja) 2013-11-29 2015-07-09 喜信 大城 サトウキビの難消化性食物繊維及びその製造方法
JP2015202057A (ja) 2014-04-11 2015-11-16 喜信 大城 食物繊維入りヨーグルトの製造方法
JP2016537996A (ja) 2013-11-18 2016-12-08 ケーエフエスユー リミテッド 酸逆流性疾患および胃食道逆流性疾患（ｇｏｒｄ／ｇｅｒｄ）の治療のための栄養補助食品
JP2017524665A (ja) 2014-06-13 2017-08-31 グラタク テクノロジーズ ピーティーワイ リミテッド 食品サプリメント

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20080227753A1 (en) * 2007-02-26 2008-09-18 Kun Lian Nano-sized Bagasse Fiber
US9245263B2 (en) * 2009-06-23 2016-01-26 Jwl Ip Holdings Llc Systems and methods for scripted content delivery
CN103355728A (zh) * 2013-07-01 2013-10-23 福建省农业科学院农业工程技术研究所 一种果汁的固定化半连续乳酸发酵方法
WO2015182530A1 (ja) * 2014-05-24 2015-12-03 アテリオ・バイオ株式会社 難消化性物質及びその製造方法
CN104814365A (zh) * 2015-05-29 2015-08-05 郭心仪 鹅饲料的制备方法
CN105685486A (zh) * 2016-01-29 2016-06-22 刘健 一种天然高纤维无臭型牛羊饲料的制备方法
CN106883968A (zh) * 2017-04-24 2017-06-23 贵州省仁怀市茅台镇永泰酒业股份有限公司 一种杨梅果酒生产方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013515051A (ja) 2009-12-22 2013-05-02 プロビ アクティエボラーグ 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用
JP2015510754A (ja) 2012-03-05 2015-04-13 グラタク テクノロジーズ ピーティーワイ リミテッド 栄養補助食品
WO2014162303A1 (en) 2013-04-05 2014-10-09 Gratuk Technologies Pty Ltd Use of a dietary fibre supplement in a food formulation
JP2016537996A (ja) 2013-11-18 2016-12-08 ケーエフエスユー リミテッド 酸逆流性疾患および胃食道逆流性疾患（ｇｏｒｄ／ｇｅｒｄ）の治療のための栄養補助食品
JP2015126727A (ja) 2013-11-29 2015-07-09 喜信 大城 サトウキビの難消化性食物繊維及びその製造方法
JP2015202057A (ja) 2014-04-11 2015-11-16 喜信 大城 食物繊維入りヨーグルトの製造方法
JP2017524665A (ja) 2014-06-13 2017-08-31 グラタク テクノロジーズ ピーティーワイ リミテッド 食品サプリメント

Also Published As

Publication number Publication date
US20210138002A1 (en) 2021-05-13
CA3103831A1 (en) 2019-12-19
JP2021527104A (ja) 2021-10-11
AU2019285375A1 (en) 2021-01-21
EP3806879A4 (en) 2022-03-09
WO2019237152A1 (en) 2019-12-19
EP3806879A1 (en) 2021-04-21
AU2019285375B2 (en) 2025-04-17

Similar Documents

Publication Publication Date Title
JP7385930B2 (ja) サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤
Dixit et al. Patents in the field of probiotics, prebiotics, synbiotics: a review
US9655932B2 (en) Composition and method for preventing or treating gout or hyperuricemia
CN110325198B (zh) 益生菌在治疗和/或预防银屑病中的用途
US11103542B2 (en) Composition and method for maintaining healthy kidney function
JP2018111711A (ja) リボフラビン、リン酸リボフラビン又は生理学上許容されるその塩
Barta et al. Biotechnological processes simulating the natural fermentation process of bee bread and therapeutic properties—an overview
JP2017537156A (ja) ゴールドキウイフルーツ組成物ならびにその調製および使用方法
CN113795155A (zh) 产生短链脂肪酸的益生菌菌株和包含该益生菌菌株的组合物
US11045509B2 (en) Tributyrin compositions and methods therefor
JP2016520305A (ja) 消化管微生物叢中のラクノスピラ科細菌及び体重との関連性
CN111528479A (zh) 一种缓解特应性皮炎功能的益生菌和益生元组合物及应用
CA2812909C (en) Compositions and methods for augmenting kidney function
Cuvas-Limón et al. Aloe vera and probiotics: a new alternative to symbiotic functional foods
Faujdar et al. Role of probiotics in human health and disease: an update
CN100402042C (zh) 增强肾功能的组合物及方法
CN115177610A (zh) 用于改善肠道微生物群的方法及组合物
US20180235270A1 (en) Probiotic beverages containing cannabinodiol
US11179426B2 (en) Composition and method for maintaining healthy kidney function
Li et al. Microencapsulation protected Lactobacillus viability and its activity in modulating the intestinal microbiota in newly weaned piglets
WO2024026529A1 (en) Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
Rajeev et al. Probiotics as a Sustainable Approach in Health Enrichment.
Chavda et al. A Glance to the Patent World of Probiotics 15
WO2025149376A1 (en) Lactiplantibacillus plantarum strain and its oral health related uses
Bhat et al. Advances in synbiotic therapy in the management of gastrointestinal diseases (enteric diseases) in farm animals

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220602

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220602

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230829

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231024

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231106

R150 Certificate of patent or registration of utility model

Ref document number: 7385930

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150